TGA rejects proposals to downschedule more ibuprofen products and Chinese medicine ingredients Proposals for the downscheduling of ibuprofen and some Chinese medicine ingredients have been rejected by the Therapeutic Goods Administration. The TGA released on Friday a series of interim decisions from its Advisory Committee on Medicines Scheduling (ACMS). One of the rejected proposals was
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.